Page last updated: 2024-08-17

galactose and Glycogen Storage Disease Type II

galactose has been researched along with Glycogen Storage Disease Type II in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Osang, M; Schaub, J	1
Banugaria, SG; Chen, YT; Finkel, RS; Kishnani, PS; Kobori, JA; Ladda, RL; Ng, YK; Prater, SN; Rosenberg, AS	1

Other Studies

2 other study(ies) available for galactose and Glycogen Storage Disease Type II

Article	Year
[Congenital enzyme deficiency in carbohydrate metabolism. Its significance for clinical pediatrics and human biochemical genetics (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1976, May-07, Volume: 118, Issue:19 Topics: Carbohydrate Metabolism, Inborn Errors; Fructose Intolerance; Fructose-1,6-Diphosphatase Deficiency; Galactose; Galactosemias; Glycogen Storage Disease Type I; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type VI; Glycogen Synthase; Humans; Infant; Infant, Newborn; Lactates; Liver; Phosphotransferases; Pyruvate Carboxylase Deficiency Disease; Pyruvate Dehydrogenase Complex Deficiency Disease; Racemases and Epimerases	1976
The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease. Genetics in medicine : official journal of the American College of Medical Genetics, 2011, Volume: 13, Issue:8 Topics: alpha-Glucosidases; Antibodies; Antibodies, Neutralizing; Biomarkers; Developmental Disabilities; Enzyme Assays; Enzyme Replacement Therapy; Female; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Heart Ventricles; Hexoses; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Organ Size	2011

Article

Year

[Congenital enzyme deficiency in carbohydrate metabolism. Its significance for clinical pediatrics and human biochemical genetics (author's transl)].

MMW, Munchener medizinische Wochenschrift, 1976, May-07, Volume: 118, Issue:19

Topics: Carbohydrate Metabolism, Inborn Errors; Fructose Intolerance; Fructose-1,6-Diphosphatase Deficiency; Galactose; Galactosemias; Glycogen Storage Disease Type I; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type VI; Glycogen Synthase; Humans; Infant; Infant, Newborn; Lactates; Liver; Phosphotransferases; Pyruvate Carboxylase Deficiency Disease; Pyruvate Dehydrogenase Complex Deficiency Disease; Racemases and Epimerases

1976

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease.

Genetics in medicine : official journal of the American College of Medical Genetics, 2011, Volume: 13, Issue:8

Topics: alpha-Glucosidases; Antibodies; Antibodies, Neutralizing; Biomarkers; Developmental Disabilities; Enzyme Assays; Enzyme Replacement Therapy; Female; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Heart Ventricles; Hexoses; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Organ Size

2011